[(5-chloro-2-methoxyphenyl)-(2-propylpyrazol-3-yl)methyl]hydrazine

C14H19ClN4O — CID 105307007

IUPAC[(5-chloro-2-methoxyphenyl)-(2-propylpyrazol-3-yl)methyl]hydrazine
SMILESCCCn1nccc1C(NN)c1cc(Cl)ccc1OC
InChIInChI=1S/C14H19ClN4O/c1-3-8-19-12(6-7-17-19)14(18-16)11-9-10(15)4-5-13(11)20-2/h4-7,9,14,18H,3,8,16H2,1-2H3
InChIKeyXLOVMBGZGMUYEE-UHFFFAOYSA-N
MW294.79 g/mol
LogP2.51
Rot. Bonds6

About [(5-chloro-2-methoxyphenyl)-(2-propylpyrazol-3-yl)methyl]hydrazine

[(5-chloro-2-methoxyphenyl)-(2-propylpyrazol-3-yl)methyl]hydrazine (PubChem CID 105307007) has the molecular formula C14H19ClN4O and a molecular weight of 294.79 g/mol. Its IUPAC name is [(5-chloro-2-methoxyphenyl)-(2-propylpyrazol-3-yl)methyl]hydrazine.

Molecular Properties

Compound Name[(5-chloro-2-methoxyphenyl)-(2-propylpyrazol-3-yl)methyl]hydrazine
PubChem CID105307007
Molecular FormulaC14H19ClN4O
Molecular Weight294.79 g/mol
Exact Mass294.12
IUPAC Name[(5-chloro-2-methoxyphenyl)-(2-propylpyrazol-3-yl)methyl]hydrazine
SMILESCCCn1nccc1C(NN)c1cc(Cl)ccc1OC
InChIInChI=1S/C14H19ClN4O/c1-3-8-19-12(6-7-17-19)14(18-16)11-9-10(15)4-5-13(11)20-2/h4-7,9,14,18H,3,8,16H2,1-2H3
InChIKeyXLOVMBGZGMUYEE-UHFFFAOYSA-N
XLogP2.51
TPSA65.10 Ų
H-Bond Donors2
H-Bond Acceptors5
Rotatable Bonds6
Heavy Atoms20
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500294.79
LogP ≤ 52.51
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 105

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'hydrazine', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'}

Analyze [(5-chloro-2-methoxyphenyl)-(2-propylpyrazol-3-yl)methyl]hydrazine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

[(2,5-dimethoxyphenyl)-(2-propylpyrazol-3-yl)methyl]hydrazine
CID 105306911
1-(4-chloro-2-methoxyphenyl)-N-methyl-1-(2-propylpyrazol-3-yl)methanamine
CID 115857351
[(2-bromo-5-methoxyphenyl)-(2-propylpyrazol-3-yl)methyl]hydrazine
CID 105307040
[(5-chloro-2-methylphenyl)-(2-ethylpyrazol-3-yl)methyl]hydrazine
CID 105307338
2-[hydrazinyl-(2-propylpyrazol-3-yl)methyl]aniline
CID 105223752
[(6-methoxypyrimidin-4-yl)-(2-propylpyrazol-3-yl)methyl]hydrazine
CID 102953226
[(5-chloro-2-methoxyphenyl)-(4-ethylsulfanylphenyl)methyl]hydrazine
CID 106850431
[(5-chloro-2-methoxyphenyl)-(2-methoxyphenyl)methyl]hydrazine
CID 105191297
N-[(3-fluoro-4-methoxyphenyl)-(2-propylpyrazol-3-yl)methyl]ethanamine
CID 115857575
[(5-chloro-2-methoxyphenyl)-(4-methoxyphenyl)methyl]hydrazine
CID 105190998
[(4-ethylsulfanylphenyl)-(2-propylpyrazol-3-yl)methyl]hydrazine
CID 106850622
[2-(3-chlorophenoxy)-1-(2-propylpyrazol-3-yl)propyl]hydrazine
CID 105306951

Frequently Asked Questions

What is the IUPAC name of [(5-chloro-2-methoxyphenyl)-(2-propylpyrazol-3-yl)methyl]hydrazine?
The IUPAC name of [(5-chloro-2-methoxyphenyl)-(2-propylpyrazol-3-yl)methyl]hydrazine (CID 105307007) is [(5-chloro-2-methoxyphenyl)-(2-propylpyrazol-3-yl)methyl]hydrazine.
What is the SMILES notation for [(5-chloro-2-methoxyphenyl)-(2-propylpyrazol-3-yl)methyl]hydrazine?
The canonical SMILES for [(5-chloro-2-methoxyphenyl)-(2-propylpyrazol-3-yl)methyl]hydrazine is CCCn1nccc1C(NN)c1cc(Cl)ccc1OC.
What is the InChIKey of [(5-chloro-2-methoxyphenyl)-(2-propylpyrazol-3-yl)methyl]hydrazine?
The InChIKey is XLOVMBGZGMUYEE-UHFFFAOYSA-N. The full InChI is InChI=1S/C14H19ClN4O/c1-3-8-19-12(6-7-17-19)14(18-16)11-9-10(15)4-5-13(11)20-2/h4-7,9,14,18H,3,8,16H2,1-2H3.
What are the key properties of [(5-chloro-2-methoxyphenyl)-(2-propylpyrazol-3-yl)methyl]hydrazine?
[(5-chloro-2-methoxyphenyl)-(2-propylpyrazol-3-yl)methyl]hydrazine has a molecular weight of 294.79 g/mol, XLogP of 2.51, 6 rotatable bonds, 2 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for [(5-chloro-2-methoxyphenyl)-(2-propylpyrazol-3-yl)methyl]hydrazine is sourced from PubChem (CID 105307007), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).